Jailendra Singh
Stock Analyst at Truist Securities
(0.94)
# 3,963
Out of 5,124 analysts
185
Total ratings
29.29%
Success rate
-24.15%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRVA Privia Health Group | Reiterates: Buy | $30 → $31 | $23.71 | +30.75% | 8 | Nov 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $4.00 | +150.00% | 8 | Nov 10, 2025 | |
| IQV IQVIA Holdings | Reiterates: Buy | $235 → $265 | $225.41 | +17.56% | 17 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $16.92 | +112.77% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $32.47 | +13.95% | 11 | Aug 18, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $187 → $234 | $182.22 | +28.42% | 10 | Jul 25, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $298 → $436 | $561.65 | -22.37% | 5 | Jul 23, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $32.75 | +55.73% | 3 | Jul 17, 2025 | |
| PGNY Progyny | Maintains: Hold | $24 → $27 | $25.68 | +5.14% | 10 | Jul 17, 2025 | |
| DOCS Doximity | Maintains: Hold | $52 → $61 | $44.28 | +37.76% | 9 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $46.45 | +3.34% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $7.00 | +28.57% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.71 | +102.95% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $4.91 | +52.75% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $24.81 | +85.41% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $223.23 | -5.93% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $9.22 | +51.84% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.69 | +843.81% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $4.60 | +182.61% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $2.80 | +1,435.71% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.88 | +733.33% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.41 | +183.69% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $205.50 | -71.78% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $2.15 | +1,993.02% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $820.29 | -59.40% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.35 | +282.98% | 2 | May 19, 2021 |
Privia Health Group
Nov 10, 2025
Reiterates: Buy
Price Target: $30 → $31
Current: $23.71
Upside: +30.75%
Evolent Health
Nov 10, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $4.00
Upside: +150.00%
IQVIA Holdings
Oct 29, 2025
Reiterates: Buy
Price Target: $235 → $265
Current: $225.41
Upside: +17.56%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $16.92
Upside: +112.77%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $32.47
Upside: +13.95%
ICON Public Limited Company
Jul 25, 2025
Maintains: Buy
Price Target: $187 → $234
Current: $182.22
Upside: +28.42%
Medpace Holdings
Jul 23, 2025
Maintains: Hold
Price Target: $298 → $436
Current: $561.65
Upside: -22.37%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $32.75
Upside: +55.73%
Progyny
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $25.68
Upside: +5.14%
Doximity
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $44.28
Upside: +37.76%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $46.45
Upside: +3.34%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $7.00
Upside: +28.57%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.71
Upside: +102.95%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $4.91
Upside: +52.75%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $24.81
Upside: +85.41%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $223.23
Upside: -5.93%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $9.22
Upside: +51.84%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.69
Upside: +843.81%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $4.60
Upside: +182.61%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $2.80
Upside: +1,435.71%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.88
Upside: +733.33%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.41
Upside: +183.69%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $205.50
Upside: -71.78%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $2.15
Upside: +1,993.02%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $820.29
Upside: -59.40%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.35
Upside: +282.98%